Lobbying client
SANGART INCORPORATED
Biopharmaceutical company dedicated to developing medicines for oxygen delivery
Filings
3
Filed by
1
Reported in-house
—
Reported by firms
$10,000
Filings
3 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
1st Quarter - Termination Amendment 1st Quarter 2010
|
CAPITOL CONSULTING GROUP, LLC | $10,000 reported |
|
1st Quarter - Reportreplaced 1st Quarter 2010
|
CAPITOL CONSULTING GROUP, LLC | $10,000 reported |
|
Registration 1st Quarter 2010
|
CAPITOL CONSULTING GROUP, LLC | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| CAPITOL CONSULTING GROUP, LLC | 1 | $10,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Medical/Disease Research/Clinical Labs | MED | 2 |
| Defense | DEF | 2 |
| Budget/Appropriations | BUD | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.